Clinical Trial Update: Clinical Study of the EASYTRAK 3 Spiral Fixation Coronary Venous Bipolar Pace/Sense Lead [Phase 2, Phase 3]

View source ↗

Summary

The update notes that the Phase 2/3 clinical study of Boston Scientific's EASYTRAK 3 spiral fixation coronary venous pace/sense lead for heart failure has compl…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Heart Failure

Drugs mentioned

• EASYTRAK 3 Spiral Fixation Coronary Venous Bipolar Pace/Sense Lead

Snippet

Sponsor: Boston Scientific Corporation | Conditions: Congestive Heart Failure | Phase 2, Phase 3 | Status: COMPLETED